Cas:935460-27-8 Cyclopropanamine, 1-[3-(tetrahydro-3-furanyl)phenyl] manufacturer & supplier

Chemical Name:Cyclopropanamine, 1-[3-(tetrahydro-3-furanyl)phenyl]

CAS.NO:935460-27-8

Synonyms:1-(3-(N-Methylamino)propyl)piperidine Hydrochloride;1-(3-(tetrahydrofuran-2-yl)phenyl)cyclopropanamine;1-(3-(tetrahydrofuran-3-yl)phenyl)cyclopropanamine

Molecular Formula:C₁₃H₁₇NO

Molecular Weight:203.28000

HS Code:2932190090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:318.5ºC at 760 mmHg

Density:1.142g/cm3

Index of Refraction:1.589

PSA:35.25000

Exact Mass:203.13100

LogP:2.83860

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 1-(3-(N-Methylamino)propyl)piperidine Hydrochloride chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-(3-(tetrahydrofuran-3-yl)phenyl)cyclopropanamine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-(3-(tetrahydrofuran-2-yl)phenyl)cyclopropanamine Use and application,1-(3-(tetrahydrofuran-3-yl)phenyl)cyclopropanamine technical grade,usp/ep/jp grade.

Related News: Trial results demonstrated that Oligomannate statistically improved cognitive function in mild-to-moderate AD patients as early as week 4 and the benefit was sustained at each follow-up assessment visit,�� Shanghai Green Valley Pharmaceuticals, which developed the drug along with two academic institutions in China, said in a statement. Cyclopropanamine, 1-[3-(tetrahydro-3-furanyl)phenyl] manufacturer In the early stage of market development, API companies usually need to strive to become a supply company for pharmaceutical companies after quickly completing product preparations. In the subsequent scale-up of production and market application, the relationship between pharmaceutical companies and API companies will become closer. The choice of R & D products of pharmaceutical companies will also be affected by pharmaceutical companies in turn. Cyclopropanamine, 1-[3-(tetrahydro-3-furanyl)phenyl] supplier Trial results demonstrated that Oligomannate statistically improved cognitive function in mild-to-moderate AD patients as early as week 4 and the benefit was sustained at each follow-up assessment visit,�� Shanghai Green Valley Pharmaceuticals, which developed the drug along with two academic institutions in China, said in a statement. Cyclopropanamine, 1-[3-(tetrahydro-3-furanyl)phenyl] vendor In the early stage of market development, API companies usually need to strive to become a supply company for pharmaceutical companies after quickly completing product preparations. In the subsequent scale-up of production and market application, the relationship between pharmaceutical companies and API companies will become closer. The choice of R & D products of pharmaceutical companies will also be affected by pharmaceutical companies in turn. Cyclopropanamine, 1-[3-(tetrahydro-3-furanyl)phenyl] factory Trial results demonstrated that Oligomannate statistically improved cognitive function in mild-to-moderate AD patients as early as week 4 and the benefit was sustained at each follow-up assessment visit,�� Shanghai Green Valley Pharmaceuticals, which developed the drug along with two academic institutions in China, said in a statement.